Nab-Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide in Neoadjuvant Chemotherapy for Resectable Breast Cancer: A Phase II Trial

BACKGROUND: The aim of this phase II study was to evaluate combined nab-paclitaxel (nab-PTX) with sequential anthracycline-based therapy as a neoadjuvant chemotherapy. METHODS: We enrolled 41 patients with advanced breast cancer (stage IIA - IIIC). All patients were to receive three-weekly nab-PTX (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World J Oncol
Hauptverfasser: Kin, Takanori, Ohtani, Shoichiro, Maeda, Reina, Ueno, Ayako, Fujihara, Miwa, Takamatsu, Yuri, Kajiwara, Yukiko, Ito, Mitsuya, Kawasaki, Kensuke, Abe, Keisuke, Sakata, Yasuhiko, Hiraki, Koichi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elmer Press 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7575276/
https://ncbi.nlm.nih.gov/pubmed/33117463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon1333
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge